Fingerprint
Dive into the research topics of 'AAV gene therapy for Duchenne muscular dystrophy: the EMBARK phase 3 randomized trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
AAV gene therapy for Duchenne muscular dystrophy: the EMBARK phase 3 randomized trial
Jerry R. Mendell, Francesco Muntoni, Craig M. McDonald, Eugenio M. Mercuri, Emma Ciafaloni, Hirofumi Komaki, Carmen Leon-Astudillo, Andrés Nascimento, Crystal Proud, Ulrike Schara-Schmidt, Aravindhan Veerapandiyan, Craig M. Zaidman, Maitea Guridi, Alexander P. Murphy, Carol Reid, Christoph Wandel, Damon R. Asher, Eddie Darton, Stefanie Mason, Rachael A. Potter
Research output: Contribution to journal › Article › peer-review
11
Scopus
citations